Application
GLYCOPEPTIDE COMPOSITIONS
Applicants
- Xellia (Denmark)
[NORA names: Xellia; Private Research]
Abstract
Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.
Patent Family Records (67)
USE OF A COMPOSITION AND AN EXCIPIENT, PHARMACEUTICAL COMPOSITION, AND, METHODS OF STABILIZING AN ANTIBIOTIC AND MANUFACTURING A STABLE AQUEOUS PHARMACEUTICAL SOLUTION
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, PINDRIC KATARINA, KESER SABINA
2024, BR-112017009405-B1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, US-20230158101-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, US-11628200-B2
Glycopeptide compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, NZ-731955-A
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, KR-20230096142-A
GLYCOPEPTIDE COMPOSITIONS
셀리아 파마슈티칼즈 에이피에스 ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2023, KR-102603756-B1
GLYCOPEPTIDE COMPOSITIONS IN SOLUTION
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, EP-4147710-A1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, US-20220354927-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, US-11517609-B2
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2022, JP-7032488-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, HR-P20210342-T8
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, CY-1124011-T1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, US-20210220433-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, US-11000567-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, SI-3542812-T1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, RS-61418-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark)
2021, PT-3542812-T
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, PL-3542812-T3
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, HU-E053347-T2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, HR-P20210342-T1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, ES-2852550-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, EP-3834837-A1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, EP-3542812-B1
GLYCOPEPTIME COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2021, DK-3542812-T3
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KESER SABINA, PINDRIC KATARINA, JASPRICA IVONA
2021, CY-1122960-T1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS Yvonne Aspritsa, Sabine Keser, Katharina Pindyck
2021, CN-107073072-B
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, US-20200069768-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, US-10849956-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, SI-3215173-T1
ANTIBIOTIC COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2020, SA-517381446-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, RS-59851-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark)
2020, PT-3215173-T
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, PL-3215173-T3
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2020, JP-6797795-B2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2020, JP-2020183424-A
Glycopeptide compositions
IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2020, IL-252120-B
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, HU-E049857-T2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, HR-P20200101-T1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, ES-2769849-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EP-3215173-B8
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EP-3215173-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EA-035368-B1
GLYCOPEPTIME COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2020, DK-3215173-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, US-20190160142-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, US-10188697-B2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, EP-3542812-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, AU-2015341763-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, Sabina KESER, IVONA JASPRICA
2018, ZA-201702767-B
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, US-20180133286-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, US-10039804-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, TN-2017000182-A1
GLYCOPEPTIDE COMPOSITIONS.
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, IVONA JASPRICA, Sabina KESER
2018, MX-2017005749-A
ANTIBIOTIC COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, CR-20170234-A
antibiotic compositions.
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER
2018, BR-112017009405-A2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS, Zellia Pharmaceuticals Aps JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, US-20170348385-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, SG-11201703568W-A
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, PH-12017500720-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, KR-20170078830-A
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2017, JP-2017533218-A
Glycopeptide compositions
IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2017, IL-252120-A0
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, EP-3215173-A1
Antibiotic compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CO-2017005391-A2
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CN-107073072-A
Antibiotic compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CL-2017001139-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, AU-2015341763-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2016, WO-2016071495-A1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2016, CA-2964524-A1